Company Overview
Snapshot
Founded in September 2020 by Moni Milchman, Benzy Shiftan, and Dima Shafranovich, InsurMedix operates with 11–50 employees. The company has raised $15 million across one funding round, with A-Labs Advisory & Finance Ltd. participating. In November 2021, InsurMedix debuted its fertility treatments insurance platform.
Business overview
InsurMedix provides a SaaS platform specializing in medical insurance for fertility and IVF treatments, complementary and alternative medicine, and outbound medical tourism. The company offers a comprehensive financial solution for fertility-related treatments, targeting young couples aged 18-45. Its platform simplifies the process of finding and comparing fertility insurance plans, aiming to make treatments more accessible and affordable. InsurMedix operates within the Fintech & Insurtech sector, specifically focusing on Insurtech, and serves the healthcare and consumer demographics markets.
Strategic signal
In November 2021, InsurMedix launched its insurtech platform to offer fertility medical insurance coverage in the US, securing $15 million in funding. This launch signals the company's strategic entry into a specialized and growing segment of the healthcare insurance market, addressing a critical need for affordable fertility treatments and positioning InsurMedix for significant growth in the US and potentially globally.
Log in to access full profile ›Company Intelligence Q&A
- What is InsurMedix's primary focus?
- InsurMedix focuses on providing a SaaS platform for medical insurance covering Fertility & IVF, Complimentary & Alternative Medicine, and Outbound Medical Tourism, aiming to make fertility treatments more accessible and affordable.
- When was InsurMedix founded and by whom?
- InsurMedix was founded in September 2020 by Moni Milchman, Benzy Shiftan, and Dima Shafranovich.
- What significant funding event has InsurMedix completed?
- In November 2021, InsurMedix raised $15 million in a funding round, with A-Labs Advisory & Finance Ltd. and Summus Venture Capital participating.
- What market does InsurMedix primarily target?
- InsurMedix targets young couples between 18-45, aiming to provide financial solutions for fertility-related treatments in the United States, with plans for global expansion.
- What is the core technology behind InsurMedix's offering?
- InsurMedix utilizes a web-based platform to facilitate the comparison and selection of fertility insurance plans, operating as a Platforms & Interfaces core technology.